First quarter 2022 results
First quarter 2022 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.
Chief Executive Officer
Jean-Baptiste de Chatillon
Chief Financial Officer
Julie Van Ongevalle
Paul Hudson comments on first quarter 2022 results
Highlights of the first quarter 2022 results
We’re off to a good start in 2022 thanks to a strong commitment to our strategy. We’re proud of the progress made in Immunology, with a broad pipeline of 13 potential new treatments in development.
Chief Executive Officer, Sanofi